 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
Hospital Eighty percent of heart failure admissions are diagnosed in the emergency departments, where the misdiagnosis rate for primary heart failure is between 10-20%. In one study, AUDICOR® helped correct approximately 34% of the missed diagnosed patients. These missed patients had 3x the incidence of pulmonary disease, less history of heart failure, and lab BNP results under the 500 pg/ml cut-off, and longer lengths of stays in the hospital. AUDICOR® is helping reduce the missed diagnosis rate and shorten length of stays by providing actionable diagnostic data at the patient’s bedside. Many hospitals are benefiting from AUDICOR® in their facilities through reductions in under or missed diagnoses, earlier initiation of treatment, shorten length of stays, and improvements on their core measure performance, which is tracked by Center for Medicare Services (CMS) and Joint Commission on Accreditation of Healthcare Organizations (JCAHO). These core measures are a hospital’s scorecard and new federal laws will begin impacting the economics of the hospital based on their performance. Studies indicate AUDICOR® used in the earliest part of the emergency department evaluation can help eliminate missed diagnosis and enable the heart failure team to undertake core measure activities. Click here to view hospital products. Collins SP, Peacock FW. Diagnostic and prognostic usefulness of AUDICOR® in dyspneic patients. Submitted for publication. Peacock WF, Emerman CL, Costanzo MR, Borkowitz RL, Cheng M. Early initiation of intravenous therapy improve heart failure outcomes: An analysis from the ADHERE registry database. Ann of Emerg Med. 2003;42(4),S26. Storrow AB, Collins SP, Peacock WF, Lindsell CJ. Length of stay and charges are increased in patients with digitally detected third heart sounds [abstract]. Acad Emerg Med. 2005;12(5):96. Abstract 262.
|
| Site Map |  |